Home > Healthcare > Biotechnology > Precision Oncology Market

Precision Oncology Market Share

Report ID: GMI7628
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Precision Oncology Market Share

The precision oncology industry is characterized by diverse players competing in the healthcare industry. Thermo Fisher Scientific Inc., Invitae Corporation, and Illumina, Inc account for significant market share. These prominent players thrive through a combination of strategic initiatives, investing in research and development, meeting the specific needs, geographical expansion, strategic approaches, product diversification, and regulatory compliance.

Foremost market players operating in the precision oncology industry is as mentioned below:

Thermo Fisher Scientific Inc.
Invitae Corporation
Illumina, Inc.
Qiagen N.V.
Novartis AG
Erasca Inc
F. Hoffmann-La Roche AG
Rain Therapeutics Inc
Agendia Inc
Strata Oncology, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Precision oncology industry reached around USD 68.7 billion in revenue in 2022 and is projected to be worth USD 184.8 billion by 2032 driven by the rising number of cancer cases globally.

The therapeutics segment held 71.7% of the precision oncology industry in 2022 and is expected to witness high demand through 2032 owing to the ongoing development of various targeted drug therapies.

North America held 43.8% revenue share of the precision oncology industry in 2022 and is estimated to expand at a notable CAGR from 2023-2032 attributed to the presence of advanced healthcare infrastructure with state-of-the-art medical facilities and technology in the region.

Some leading precision oncology companies are Thermo Fisher Scientific Inc., Invitae Corporation, Illumina, Inc., Qiagen N.V., Novartis AG, F. Hoffmann-La Roche AG, Rain Therapeutics Inc, and Strata Oncology, Inc.